Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double‐blind controlled study in general practice
- 19 April 2006
- journal article
- clinical trial
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 21 (3), 139-149
- https://doi.org/10.1002/hup.757
Abstract
Adjustment Disorders With Anxiety (ADWA) account for almost 10% of psychologically motivated consultations in primary care. The aim of this double‐blind randomised parallel group study was to compare (non‐inferiority test) the efficacies of etifoxine, a non‐benzodiazepine anxiolytic drug, and lorazepam, a benzodiazepine, for ADWA outpatients followed by general practitioners. 191 outpatients (mean age: 43, female: 66%) were assigned to receive etifoxine (50 mg tid) or lorazepam (0.5‐0.5‐1 mg /day) for 28 days. Efficacy was evaluated on days 7 and 28 of the treatment. The main efficacy assessment criterion was the Hamilton Rating Scale for Anxiety score (HAM‐A) on Day 28 adjusted to Day 0. The anxiolytic effect of etifoxine was found not inferior to that of lorazepam (HAM‐A score decrease: 54.6% vs 52.3%, respectively, p = 0.0006). The two drugs were equivalent on Day 28. However, more etifoxine recipients responded to the treatment (HAM‐A score decreased by ≥50%, p = 0.03). Clinical improvement (based on Clinical Global Impression scale CGI, Social Adjustment Scale Self‐Report SAS‐SR, and Sheehan scores) was observed in both treatment arms, but more etifoxine patients improved markedly (p = 0.03) and had a marked therapeutic effect without side effects as assessed by CGI, p = 0.04. Moreover, 1 week after stopping treatment, fewer patients taking etifoxine experienced a rebound of anxiety, compared to lorazepam (1 and 8, respectively, p = 0.034). Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 38 references indexed in Scilit:
- Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in ratsPhysiology & Behavior, 2004
- Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended releaseEuropean Psychiatry, 2004
- The modulatory effects of the anxiolytic etifoxine on GABAA receptors are mediated by the β subunitNeuropharmacology, 2003
- Interactions of etifoxine with the chloride channel coupled to the GABAA receptor complexNeuroReport, 1999
- Gepirone and Diazepam in Generalized Anxiety DisorderJournal of Clinical Psychopharmacology, 1997
- Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability ScaleThe International Journal of Psychiatry in Medicine, 1997
- Pharmacokinetic-Pharmacodynamic Relationships For BenzodiazepinesClinical Pharmacokinetics, 1996
- Guidelines for the Rational Use of BenzodiazepinesDrugs, 1994
- Effects of low doses of lorazepam on psychometric tests in healthy volunteersInternational Clinical Psychopharmacology, 1994
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959